Palantir Technologies (PLTR): Momentum or Reversal? Key Levels i
🔥 LucanInvestor’s Commands:
🩸 Resistance: $80.00. A breakout above this level targets $83 and $85, supported by strong bullish sentiment.
🩸 Support: $77.50. A breakdown exposes $75 and $72, indicating potential corrective movement.
🔥 LucanInvestor’s Strategy:
🩸 Long: Above $80.00, aiming for $83 and $85. Strong volume is crucial to sustain the breakout.
🩸 Short: Below $77.50, targeting $75 and $72. Bears gain control with increasing selling pressure.
🩸 Palantir’s MACD shows weakening momentum, suggesting consolidation after a strong rally. However, the price remains above its 200 EMA, indicating a solid bullish foundation. Watch for confirmation at $80 with high buying volume to ride the upward trend, while loss of $77.50 could lead to further pullback. The stock's year-to-date gain of 366.55% highlights its long-term strength, making it a key focus for traders and investors alike.
👑 "In every pause, there’s potential. The bold seize it; the hesitant lose it." — LucanInvestor
🩸 Resistance: $80.00. A breakout above this level targets $83 and $85, supported by strong bullish sentiment.
🩸 Support: $77.50. A breakdown exposes $75 and $72, indicating potential corrective movement.
🔥 LucanInvestor’s Strategy:
🩸 Long: Above $80.00, aiming for $83 and $85. Strong volume is crucial to sustain the breakout.
🩸 Short: Below $77.50, targeting $75 and $72. Bears gain control with increasing selling pressure.
🩸 Palantir’s MACD shows weakening momentum, suggesting consolidation after a strong rally. However, the price remains above its 200 EMA, indicating a solid bullish foundation. Watch for confirmation at $80 with high buying volume to ride the upward trend, while loss of $77.50 could lead to further pullback. The stock's year-to-date gain of 366.55% highlights its long-term strength, making it a key focus for traders and investors alike.
👑 "In every pause, there’s potential. The bold seize it; the hesitant lose it." — LucanInvestor
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.